GSK’s financials: CEO Walmsley touts results, expectations via video
GSK’s latest quarterly financials released early Wednesday in London include an upgrade in expectations. Watch CEO Emma Walmsley’s video summary.
Read MorePosted by WRAL TechWire | Nov 1, 2023
GSK’s latest quarterly financials released early Wednesday in London include an upgrade in expectations. Watch CEO Emma Walmsley’s video summary.
Read MorePosted by WRAL TechWire | Jul 26, 2023
GSK CEO Emma Walmsley delivered an upbeat video overview of the drug giant’s latest financial report on Wednesday. And in a statement she further amplified her remarks. But adding to her smile: what the financial report and a positive look ahead could mean for her.
Read MorePosted by WRAL TechWire | Apr 26, 2023
Watch GSK CEO Emma Walmsley’s video update on the drug giant’s quarterly financials and catch Reuters’ coverage: GSK stays strong as healthy sales beat expectations.
Read MorePosted by WRAL TechWire | Feb 1, 2023
Drug giant GSK reported early Wednesday profits and revenues which beat expectations, and CEO Emma Walmsley delivered an upbeat summary of company performance. But some analysts are concerned about its pipeline.
Read MorePosted by WRAL TechWire | Jul 27, 2022
The new look GSK disclosed its latest quartertly financials early Wednesday, and CEO Emma Walmsley discusses the results in a video while providing a corporate update in the detailed announcement.
Read MorePosted by WRAL TechWire | Apr 27, 2022
GlaxoSmithKline disclosed its latest financials report Wednesday in London, and CEO Emma Walmsley offered her analysis via YouTube. You can watch it at this link.
Read MorePosted by WRAL TechWire | Feb 9, 2022
RESEARCH TRIANGLE PARK – GlaxoSmithKline CEO Emma Walmsley sees 2022 as a “landmark year” after the drug giant rejected a bid from Unilever for its consumer health business and plans to move ahead with a spinoff. “We have ended the year strongly, with another quarter of excellent performance driven...
Read MorePosted by WRAL TechWire | Jul 2, 2021
GlaxoSmithKline CEO Emma Walmsley is getting a big sign of support in a growing dispute with an activist hedge fund that has hinted Walmsley should be replaced.
Read MorePosted by WRAL TechWire | Oct 28, 2020
Drugmaker GlaxoSmithKline says third-quarter earnings fell 14.4% as disruptions caused by the COVID-19 pandemic reduced sales of vaccines, antibiotics and consumer healthcare products. But CEO Emma Walmsley remains optimistic.
Read More